Anzeige
Mehr »
Login
Samstag, 21.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 866251 | ISIN: US09061H3075 | Ticker-Symbol:
NASDAQ
20.12.24
20:33 Uhr
0,275 US-Dollar
+0,009
+3,46 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOMERICA INC Chart 1 Jahr
5-Tage-Chart
BIOMERICA INC 5-Tage-Chart

Aktuelle News zur BIOMERICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans-
DiBIOMERICA INC - 8-K, Current Report-
25.11.BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans-
21.11.Biomerica secures patents for GI treatments in Europe1
21.11.Biomerica, Inc.: Biomerica Secures Three Key International Patents for inFoods Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis1
07.11.Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements101IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day...
► Artikel lesen
BIOMERICA Aktie jetzt für 0€ handeln
07.11.Biomerica erhält Fristverlängerung zur Wiedererlangung der Nasdaq-Konformität1
07.11.Biomerica granted extension to regain Nasdaq compliance1
06.11.BIOMERICA INC - 8-K, Current Report-
30.10.Biomerica, Inc.: Biomerica Announces Direct-to-Consumer Availability of inFoods IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain1
16.10.Biomerica reports Q1 results1
16.10.Biomerica, Inc.: Biomerica Reports First Quarter Fiscal 2025 Financial Results111Total Revenue Increases 6% Over Same Period Last Year Cost-Saving Measures Now Implemented, Expected to Reduce Annual Expenses by 16% to 23%, Representing $1.0 to $1.4 Million ReductionBiomerica's...
► Artikel lesen
15.10.BIOMERICA INC - 10-Q, Quarterly Report1
04.09.Saudi Arabia approves Biomerica's prostate cancer test1
04.09.Biomerica, Inc.: The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer1
29.08.Biomerica reports FY results1
29.08.Biomerica, Inc.: Biomerica Reports Fiscal 2024 Year End Results445Total Revenue Increases 1% Year-Over-Year - Core Revenue Excluding COVID Tests Climbs 5%, Reflecting Stronger GrowthSignificant Cost Savings Plan Implemented After Year End - Expected to Deliver Expense...
► Artikel lesen
28.08.BIOMERICA INC - 10-K, Annual Report2
01.07.Biomerica, Inc.: Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers1
28.06.BIOMERICA INC - 8-K, Current Report1
Seite:  Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1